DCSIMG
NIH Guidelines – Low-Dose ICS (Pediatric)

For The Treatment Of Asthma, NIH Guidelines Suggest(1)

  • Low-dose inhaled corticosteroid (ICS) agents as the preferred daily treatment option for long-term management of mild persistent asthma
  • A stepwise approach to asthma therapy to gain control of asthma symptoms and to achieve control at the lowest effective dose*

* The stepwise approach presents guidelines to assist clinical decision making. Asthma is highly variable; physicians should tailor specific medication plans to the needs and circumstances of individual patients.1